Pharmaceutical

PF-07872412 by Pfizer for Streptococcal Pneumonia: Likelihood of Approval

PF-07872412 is under clinical development by Pfizer and currently in Phase I for Streptococcal Pneumonia.

Feb 20, 2024 - 18:00
PF-07872412 is under clinical development by Pfizer and currently in Phase I for Streptococcal Pneumonia.
Read the original article

Tags:

Previous Article

INV-347 by Inversago Pharma for Obesity: Likelihood of Approval

Next Article

NA-921 by Biomed Industries for Rett Syndrome: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA advisory panel narrowly recommends approval for Sarepta’s gene therapy for Duchenne

STAT+: FDA advisory panel narrowly recommends approval ...

May 13, 2023

Another recall: does Philips have a quality control problem?

Another recall: does Philips have a quality control pro...

Feb 10, 2024

STAT+: J&J to emphasize cancer drugs and stop much of its vaccine research

STAT+: J&J to emphasize cancer drugs and stop much of i...

Dec 5, 2023